In a report released today, Serge Belanger from Needham maintained a Hold rating on Zynerba Pharmaceuticals (ZYNE - Research Report). The company's shares opened today at $1.25.Belanger covers the Healthcare sector, focusing on stocks such as Pacira Pharmaceuticals, Cytokinetics, and Amphastar Pharmaceuticals. According to TipRanks, Belanger has an average return of 6.4% and a 47.06% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zynerba Pharmaceuticals with a $9.50 average price target.
https://www.tipranks.com/news/blurbs/zynerba-pharmaceuticals-zyne-gets-a-hold-from-needham?utm_source=advfn.com&utm_medium=referral
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Zynerba Pharmaceuticals Charts.
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Zynerba Pharmaceuticals Charts.